GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Siemens Healthineers AG (OTCPK:SMMNY) » Definitions » Beneish M-Score

Siemens Healthineers AG (Siemens Healthineers AG) Beneish M-Score : -2.63 (As of Apr. 27, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Siemens Healthineers AG Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.63 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Siemens Healthineers AG's Beneish M-Score or its related term are showing as below:

SMMNY' s Beneish M-Score Range Over the Past 10 Years
Min: -2.73   Med: -2.54   Max: 0.84
Current: -2.63

During the past 9 years, the highest Beneish M-Score of Siemens Healthineers AG was 0.84. The lowest was -2.73. And the median was -2.54.


Siemens Healthineers AG Beneish M-Score Historical Data

The historical data trend for Siemens Healthineers AG's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Siemens Healthineers AG Beneish M-Score Chart

Siemens Healthineers AG Annual Data
Trend Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only -2.49 -2.13 -2.49 -2.39 -2.58

Siemens Healthineers AG Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.40 -2.55 -2.53 -2.58 -2.63

Competitive Comparison of Siemens Healthineers AG's Beneish M-Score

For the Medical Devices subindustry, Siemens Healthineers AG's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Siemens Healthineers AG's Beneish M-Score Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Siemens Healthineers AG's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Siemens Healthineers AG's Beneish M-Score falls into.



Siemens Healthineers AG Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Siemens Healthineers AG for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.9582+0.528 * 1.0363+0.404 * 0.9731+0.892 * 1.0286+0.115 * 0.9392
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.0379+4.679 * -0.018251-0.327 * 1.0671
=-2.61

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Total Receivables was $6,978 Mil.
Revenue was 5644.493 + 6463.18 + 5634.886 + 5723.769 = $23,466 Mil.
Gross Profit was 2141.767 + 2447.172 + 2097.508 + 1737.687 = $8,424 Mil.
Total Current Assets was $15,093 Mil.
Total Assets was $49,652 Mil.
Property, Plant and Equipment(Net PPE) was $4,568 Mil.
Depreciation, Depletion and Amortization(DDA) was $1,630 Mil.
Selling, General, & Admin. Expense(SGA) was $3,909 Mil.
Total Current Liabilities was $13,528 Mil.
Long-Term Debt & Capital Lease Obligation was $498 Mil.
Net Income was 470.011 + 573.106 + 482.124 + 112.42 = $1,638 Mil.
Non Operating Income was 0 + 0 + 0 + 0 = $0 Mil.
Cash Flow from Operations was 403.49 + 851.654 + 516.793 + 771.949 = $2,544 Mil.
Total Receivables was $7,081 Mil.
Revenue was 5378.178 + 5940.594 + 5482.03 + 6013.216 = $22,814 Mil.
Gross Profit was 1967.161 + 2299.01 + 1975.687 + 2245.595 = $8,487 Mil.
Total Current Assets was $14,347 Mil.
Total Assets was $49,378 Mil.
Property, Plant and Equipment(Net PPE) was $4,379 Mil.
Depreciation, Depletion and Amortization(DDA) was $1,436 Mil.
Selling, General, & Admin. Expense(SGA) was $3,662 Mil.
Total Current Liabilities was $12,618 Mil.
Long-Term Debt & Capital Lease Obligation was $454 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(6978.19 / 23466.328) / (7080.508 / 22814.018)
=0.29737 / 0.310358
=0.9582

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(8487.453 / 22814.018) / (8424.134 / 23466.328)
=0.372028 / 0.358988
=1.0363

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (15092.694 + 4568.157) / 49652.126) / (1 - (14347.458 + 4379.237) / 49378.178)
=0.604028 / 0.62075
=0.9731

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=23466.328 / 22814.018
=1.0286

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(1436.075 / (1436.075 + 4379.237)) / (1629.646 / (1629.646 + 4568.157))
=0.246947 / 0.262939
=0.9392

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(3909.213 / 23466.328) / (3661.666 / 22814.018)
=0.166588 / 0.160501
=1.0379

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((498.364 + 13527.808) / 49652.126) / ((454.449 + 12617.585) / 49378.178)
=0.282489 / 0.264733
=1.0671

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(1637.661 - 0 - 2543.886) / 49652.126
=-0.018251

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Siemens Healthineers AG has a M-score of -2.61 suggests that the company is unlikely to be a manipulator.


Siemens Healthineers AG Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Siemens Healthineers AG's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Siemens Healthineers AG (Siemens Healthineers AG) Business Description

Traded in Other Exchanges
Address
Siemensstr. 3, Forchheim, BY, DEU, 91301
Siemens Healthineers AG is engaged in the fields of diagnostic, therapeutic imaging, laboratory and point of care diagnostics as well as clinical consulting services. The imaging segment products equipment include magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging and ultrasound. The portfolio of the Diagnostics segment includes; immunochemistry, hematology, coagulation, urinalysis, etc. Advanced Therapies segment products are designed to support image-guided minimally invasive treatments in cardiology, interventional radiology and surgery. Varian segment provides multi-modality cancer care technologies, solutions and services to oncology departments in hospitals and clinics. It caters and earns revenue from Europe, the Middle East, Africa, China and others.